Details of issuance or disposal
Issue of new shares through a public offering (general offering), issue of new shares through a third-party allotment, and secondary offering of the Company's shares (over-allotment offering)
Public offering of new shares: 4,694,600 shares (total issue price of ¥14,797,379,200, the stated number of shares calculated at an issue price of ¥3,152 per share); over-allotment offering: 704,100 shares; third-party allotment of new shares: 704,100 shares (maximum total payment amount of ¥2,127,790,200, the maximum number of shares calculated at a payment amount of ¥3,022 per share)
The lower thin line represents the existing number of shares to which these shares will be added.
Public offering: ¥14,797,379,200 (total issue price); third-party allotment: Not disclosed (maximum total payment amount of ¥2,127,790,200)
| Item | Details |
|---|---|
| Type of issuance or disposal | Issue of new shares through a public offering (general offering), issue of new shares through a third-party allotment, and secondary offering of the Company's shares (over-allotment offering) |
| Number of shares to be issued or disposed of | Public offering of new shares: 4,694,600 shares (total issue price of ¥14,797,379,200, the stated number of shares calculated at an issue price of ¥3,152 per share); over-allotment offering: 704,100 shares; third-party allotment of new shares: 704,100 shares (maximum total payment amount of ¥2,127,790,200, the maximum number of shares calculated at a payment amount of ¥3,022 per share) |
| Issue price and disposal price | Public offering: ¥3,022 per share (payment amount); third-party allotment: ¥3,022 per share; public offering issue price and offering price: ¥3,152 per share |
| Total issue value | Public offering: ¥14,797,379,200 (total issue price); third-party allotment: Not disclosed (maximum total payment amount of ¥2,127,790,200) |
| Amount of funds to be raised | Total payment amount: ¥14,187,081,200 for the public offering and a maximum of ¥2,127,790,200 for the third-party allotment; estimated net proceeds: maximum of ¥16,217,871,400 from the general offering and the third-party allotment |
| Specific use of funds | Details Capital expenditures for the Company's supermarket business / Amount ¥279,000,000 / Scheduled timing of expenditures Through the end of February 2027, Details Capital expenditures through loans and investments in subsidiaries / Amount ¥15,938,871,400 / Scheduled timing of expenditures By the end of March 2028, Details Opening new stores for the drugstore business, home improvement center business, and supermarket business, including the Motohaneida and Honmoku stores in the Kanto area / Amount ¥11,614,000,000 / Scheduled timing of expenditures By the end of March 2028, Details Capital expenditures for food-processing plants in the supermarket business / Amount ¥2,130,000,000 / Scheduled timing of expenditures Through the end of February 2027, Details Store-related capital expenditures for the supermarket and drugstore businesses / Amount ¥2,194,871,400 / Scheduled timing of expenditures Through the end of March 2027 |
| Payment date | Public offering: 15 July 2026; third-party allotment: 13 August 2026 |
| Intended allottee | Public offering: an unspecified number of investors; third-party allotment: Not disclosed (however, the number of shares offered in the over-allotment offering is 704,100) |
| Basis for determining the amount to be paid | A 3.02% discount to the closing price of ¥3,250 on 8 July 2026, the pricing reference date. The issue price and offering price are ¥3,152, and the payment amount is ¥3,022 |
| Overallotment | Shares offered: 704,100; maximum total payment amount for the new shares issued through the third-party allotment: ¥2,127,790,200 (equivalent to a maximum of 704,100 shares) |
| Most recent equity financing | Issue of new shares and secondary offering of shares approved on 30 June 2026 (this offering) |
Items this document does not state (17)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To announce the determination of the issue price and other terms. The funds raised are planned to be used for capital investment in the supermarket business and in each business operated through subsidiaries.